Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage Mariann HarangiIldikó SeresÉva Remenyik Pharmacodynamics 14 October 2004 Pages: 685 - 691
Absorption kinetics and pharmacodynamics of two oral dosage forms of flecainide in patients with an episode of paroxysmal atrial fibrillation V. H. M. DeneerL. Lie-A-HuenJ. R. B. J. Brouwers Pharmacodynamics 16 November 2004 Pages: 693 - 701
Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients M. BüchlerP. LeibenguthG. Paintaud Pharmacodynamics 20 November 2004 Pages: 703 - 708
Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria Jens RengelshausenJürgen BurhenneIngeborg Walter-Sack Pharmacokinetics and Disposition 13 October 2004 Pages: 709 - 715
Pharmacokinetics of intravenous N-acetylcysteine in men at rest and during exercise Malcolm BrownAndrew BjorkstenMichael McKenna Pharmacokinetics and Disposition 20 November 2004 Pages: 717 - 723
Medical speciality and pattern of medicines prescription A. VallanoE. MontanéJ. R. Laporte Pharmacoepidemiology and Prescription 16 October 2004 Pages: 725 - 730
Pattern of NSAID use in the Italian general population: a questionnaire-based survey Domenico MotolaAlberto VaccheriNicola Montanaro Pharmacoepidemiology and Prescription 26 October 2004 Pages: 731 - 738
Prescribing indicators Paul E. M. MuijrersRob JanknegtJ. André Knottnerus Pharmacoepidemiology and Prescription 26 October 2004 Pages: 739 - 746
Postmarketing surveillance of potentially fatal reactions to oncology drugs: potential utility of two signal-detection algorithms Manfred HaubenLester ReichStephanie Chung Pharmacoepidemiology and Prescription 17 November 2004 Pages: 747 - 750
Diffusion of the new antiepileptic drug lamotrigine in Dutch clinical practice P. D. KnoesterS. V. BelitserY. A. Hekster Pharmacoepidemiology and Prescription 20 November 2004 Pages: 751 - 758